Charles River Laboratories Announces Third-Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Charles River Laboratories (CRL) Tops Q3 EPS by 6c, Updates Guidance
November 6, 2019 7:13 AM ESTCharles River Laboratories (NYSE: CRL) reported Q3 EPS of $1.69, $0.06 better than the analyst estimate of $1.63. Revenue for the quarter came in at $668 million versus the consensus estimate of $672.74 million.
GUIDANCE:
Charles River Laboratories sees FY2019 EPS of $6.50-$6.60, versus... More
